One of the pioneers of research in clinical cardiology, Professor Christian Torp-Pedersen, held on March 29 the Novo Nordisk Prize lecture 2016. This was the first time the Prize was received by a Professor at the Faculty of Medicine at Aalborg University.
The risk of dying from cardiovascular disease has been halved in Denmark during the past 20 years. This trend has resulted from better prevention and treatment. New knowledge gained from research has largely enabled these improvements. Christian Torp-Pedersen has authored or co-authored more than 500 scientific articles published in such highly renowned journals as The New England Journal of Medicine and The Lancet.
Jan Fahrenkrug, Chair of the Novo Nordisk Prize Committee, says: “Christian Torp-Pedersen’s original, comprehensive and systematic research within cardiology and epidemiology is highly esteemed internationally and has had major influence on clinical practice and guidelines. He has displayed great leadership and has inspired and supervised numerous young researchers.”
Many of Christian Torp-Pedersen’s 30 current and former Ph D students were also present at the lecture along the rector of Aalborg University Per Michael Johansen and Dean of the Faculty of Medicine, Per Hvilsted Rasmussen. Both were happy and proud like the laureate himself.
“I am extremely pleased and surprised to be awarded the Prize. Most researchers only know whether they are appreciated within their own field, so achieving this honour is fantastic. One reason why I am surprised is that epidemiology is not normally ranked highly as a research field. So I am also very happy that epidemiology is being recognized through this Prize,” Christian Torp-Pedersen explained.
Christian Torp-Pedersen formelt received the Novo Nordisk Prize on 15 March 2016. Read more about the prize here.
ABOUT CHRISTIAN TORP-PEDERSEN
Professor, Department of Health Science and Technology, Aalborg University
THE NOVO NORDISK PRIZE:
The Prize is awarded annually to recognize unique medical research or other research contributions that benefit medical science. The Prize is awarded for a predominantly Danish contribution. The Novo Nordisk Prize Committee awards the Prize based on suggestions from past Prize winners or members of the Prize Committee.
Christian Torp-Pedersen, Department of Health Science and Technology, Aalborg University, firstname.lastname@example.org, tel. +45 9940 3802
Jan Fahrenkrug, Chair of the Novo Nordisk Prize Committee, email@example.com, mobile: +45 6168 4752
Christian Mostrup Scheel, Press Officer, Novo Nordisk Foundation, firstname.lastname@example.org, mobile: +45 3067 4805